Glimecaid-MP 1 Tablet SR
Marketer
Medicaid Labs LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimecaid-MP 1 Tablet SR
Diabetic patients utilizing Glimecaid-MP 1 SR Tablet, a dual-action formulation, experience improved glycemic management. This medication, used in conjunction with a healthy diet and regular exercise, aids adults with type 2 diabetes in better regulating blood sugar. Its mechanism enhances insulin effectiveness, consequently reducing blood glucose. Adhere strictly to your physician's prescribed dosage and regimen for Glimecaid-MP 1 SR Tablet; consume it with food to minimize gastrointestinal distress. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol, or meal skipping elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal discomfort, cephalalgia, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any renal, hepatic, or cardiac issues to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment precedes treatment initiation. Limit alcohol consumption to mitigate potential side effect exacerbation.
Uses of Glimecaid-MP 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimecaid-MP 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Glimecaid-MP 1 SR tablet with a meal.
Common Side effects of Glimecaid-MP 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimecaid-MP 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Glimecaid-MP SR tablet with a meal.
How Glimecaid-MP 1 Tablet SR works:
Glimecaid-MP SR, a single-tablet formulation, combines the antidiabetic actions of glimepiride, metformin, and pioglitazone. These three agents employ distinct mechanisms to optimize blood glucose management when monotherapy or dual-drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimecaid-MP 1 Tablet SR with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimecaid-MP 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimecaid-MP 1 Tablet SR while breastfeeding is likely unsafe. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Glimecaid-MP 1 Tablet SR, potentially requiring dosage modification. Consult your physician for guidance. Glimecaid-MP 1 Tablet SR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimecaid-MP 1 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimecaid-MP 1 Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimecaid-MP 1 Tablet SR :
Should you forget to take a Glimecaid-MP 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimecaid-MP 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


